BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27283255)

  • 1. Statin use may reduce lower extremity peak force via reduced engagement in muscle-strengthening activities.
    Loenneke JP; Loprinzi PD
    Clin Physiol Funct Imaging; 2018 Jan; 38(1):151-154. PubMed ID: 27283255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in muscle strength in patients with statin myalgia.
    Panza GA; Taylor BA; Roman W; Thompson PD
    Am J Cardiol; 2014 Oct; 114(8):1215-6. PubMed ID: 25171803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in muscle strength in individuals with statin-induced myopathy: A summary of 3 investigations.
    Panza GA; Taylor BA; Dada MR; Thompson PD
    J Clin Lipidol; 2015; 9(3):351-6. PubMed ID: 26073393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy.
    Taylor BA; Lorson L; White CM; Thompson PD
    Atherosclerosis; 2015 Feb; 238(2):329-35. PubMed ID: 25545331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin's impact on statin-associated muscle symptoms: An analysis of ACCORD study data and research materials from the NHLBI Biologic Specimen and Data Repository Information Coordinating Center.
    Carris NW; Tsalatsanis A; Tipparaju SM; Cheng F; Magness RR; Kumar A
    Diabetes Obes Metab; 2018 Aug; 20(8):1994-1999. PubMed ID: 29577553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability.
    Rosenson RS; Miller K; Bayliss M; Sanchez RJ; Baccara-Dinet MT; Chibedi-De-Roche D; Taylor B; Khan I; Manvelian G; White M; Jacobson TA
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):179-186. PubMed ID: 28421332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single and combined associations of accelerometer-assessed physical activity and muscle-strengthening activities on plasma homocysteine in a national sample.
    Buckner SL; Loenneke JP; Loprinzi PD
    Clin Physiol Funct Imaging; 2017 Nov; 37(6):669-674. PubMed ID: 26916173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between muscle strengthening activities and red blood cell distribution width among a national sample of U.S. adults.
    Loprinzi PD; Loenneke JP; Abe T
    Prev Med; 2015 Apr; 73():130-2. PubMed ID: 25602910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights Into Statin Intolerance.
    Kopecky S; Baum S; Foody JM; Koren M; McKenney J; Sperling L; Wong ND;
    Clin Cardiol; 2015 Sep; 38(9):520-6. PubMed ID: 26337173
    [No Abstract]   [Full Text] [Related]  

  • 10. Lower Extremity Muscular Strength and Leukocyte Telomere Length: Implications of Muscular Strength in Attenuating Age-Related Chronic Disease.
    Loprinzi PD; Loenneke JP
    J Phys Act Health; 2016 Apr; 13(4):454-7. PubMed ID: 26314088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerobic Exercise Performance and Muscle Strength in Statin Users-The LIFESTAT Study.
    Morville T; Dohlmann TL; Kuhlman AB; Sahl RE; Kriegbaum M; Larsen S; Dela F; Helge JW
    Med Sci Sports Exerc; 2019 Jul; 51(7):1429-1437. PubMed ID: 31210648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D status modifies the association between statin use and musculoskeletal pain: a population based study.
    Morioka TY; Lee AJ; Bertisch S; Buettner C
    Atherosclerosis; 2015 Jan; 238(1):77-82. PubMed ID: 25437894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle symptoms in statin users, associations with cytochrome P450, and membrane transporter inhibitor use: a subanalysis of the USAGE study.
    Ito MK; Maki KC; Brinton EA; Cohen JD; Jacobson TA
    J Clin Lipidol; 2014; 8(1):69-76. PubMed ID: 24528687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin-associated muscle injury.
    Ballard KD; Taylor BA; Thompson PD
    Eur J Prev Cardiol; 2015 Sep; 22(9):1161. PubMed ID: 25948131
    [No Abstract]   [Full Text] [Related]  

  • 15. Patients experiencing statin-induced myalgia exhibit a unique program of skeletal muscle gene expression following statin re-challenge.
    Elam MB; Majumdar G; Mozhui K; Gerling IC; Vera SR; Fish-Trotter H; Williams RW; Childress RD; Raghow R
    PLoS One; 2017; 12(8):e0181308. PubMed ID: 28771594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological investigation of muscle-strengthening activities and cognitive function among older adults.
    Loprinzi PD
    Chronic Illn; 2016 Jun; 12(2):157-62. PubMed ID: 27048445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle-related side-effects of statins: from mechanisms to evidence-based solutions.
    Taylor BA; Thompson PD
    Curr Opin Lipidol; 2015 Jun; 26(3):221-7. PubMed ID: 25943841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study.
    Pedro-Botet J; Millán Núñez-Cortés J; Chillarón JJ; Flores-Le Roux JA; Rius J
    Expert Opin Drug Saf; 2016 Dec; 15(12):1583-1587. PubMed ID: 27645494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower extremity strength, systemic inflammation and all-cause mortality: Application to the "fat but fit" paradigm using cross-sectional and longitudinal designs.
    Buckner SL; Loenneke JP; Loprinzi PD
    Physiol Behav; 2015 Oct; 149():199-202. PubMed ID: 26072175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the relationship between statins and physical activity.
    Panza GA; Taylor BA; Thompson PD
    Curr Opin Cardiol; 2016 Sep; 31(5):572-9. PubMed ID: 27428007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.